Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 951 JPY -1.86% Market Closed
Market Cap: 26.7B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Relative Value

The Relative Value of one Pharma Foods International Co Ltd stock under the Base Case scenario is 3 956.38 JPY. Compared to the current market price of 951 JPY, Pharma Foods International Co Ltd is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 956.38 JPY
Undervaluation 76%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
91
Median 3Y
0.6
Median 5Y
0.9
Industry
7.7
vs History
57
vs Industry
11
Median 3Y
7.9
Median 5Y
11.4
Industry
22.7
vs History
44
vs Industry
14
Median 3Y
4.7
Median 5Y
4.7
Industry
21.6
vs History
9
vs Industry
11
Median 3Y
8.5
Median 5Y
8.5
Industry
25.2
vs History
93
vs Industry
31
Median 3Y
5.3
Median 5Y
6.5
Industry
2.5
vs History
87
vs Industry
81
Median 3Y
0.7
Median 5Y
0.9
Industry
7.7
vs History
85
vs Industry
77
Median 3Y
0.9
Median 5Y
1.1
Industry
9
vs History
69
vs Industry
12
Median 3Y
5.7
Median 5Y
11.5
Industry
4.2
vs History
69
vs Industry
10
Median 3Y
6
Median 5Y
12.5
Industry
4.1
vs History
44
vs Industry
14
Median 3Y
4.9
Median 5Y
4.9
Industry
5.7
vs History
38
vs Industry
10
Median 3Y
5.6
Median 5Y
3.9
Industry
3.6
vs History
90
vs Industry
50
Median 3Y
2.3
Median 5Y
2.7
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Pharma Foods International Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Pharma Foods International Co Ltd
TSE:2929
26.7B JPY 0.4 8.3 4.5 5.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
JP
Pharma Foods International Co Ltd
TSE:2929
Average P/E: 174.9
8.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
Pharma Foods International Co Ltd
TSE:2929
Average EV/EBITDA: 15.3
4.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
JP
Pharma Foods International Co Ltd
TSE:2929
Average EV/EBIT: 20
5.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top